A chemist with a molecule that may never leave the lab. A founder signing a contract nobody fully read. A developer rebuilding a screen the designer already drew. A rider job-hunting in a language the portal doesn’t speak. Someone who feels perfectly fine.
5 very different problems. 5 Indian AI startups worth knowing about.
This week, #OnTheRadar:
01 | Boltzmann Labs · Drug discovery
Most drug candidates fail, and they fail late, after years of work and a lot of money. Boltzmann Labs builds AI across that process, from designing a molecule to working out how it could be synthesised in a lab, and then runs its own discovery programmes on the platform rather than only licensing it out.
🟢 Built by Sarath Kolli and Paritosh Prashar | Since 2019
↓
02 | Lexapar · Legaltech
Legal review is usually where a fast-moving company slows down. Lexapar reviews contracts, flags the clauses that carry real risk and lets a company set playbooks so the same question isn’t re-argued each time, while being careful to say it is not a law firm and that a licensed professional stays in the loop.
🟢 Built by Rishi Shroff and Atishay Garg | Since 2021
↓
03 | Kombai · Developer tools
A designer finishes a screen in Figma and a developer then rebuilds it by hand. Kombai converts the design into front-end code, grouping elements the way a developer would and splitting it into named components, and it is far less of a language model product than it sounds, with LLMs accounting for under 5% of the output.
🟢 Built by Dipanjan Dey and Abhijit Bhole | Since 2022
↓
04 | Vahan · Hiring
Hiring for blue-collar roles in India still happens over the phone, at a volume no recruitment team can staff for. Vahan runs a voice-first AI recruiter that speaks to candidates in their own language and handles most of the screening, with no app to download and no form to fill in, because every extra step in that journey loses people.
🟢 Built by Madhav Krishna | Since 2016
↓
05 | Cent · Preventive healthcare
Preventive healthcare in India usually amounts to a cheap annual blood panel that tells you very little. Cent sells one annual protocol instead, a full-body MRI, heart CT, DEXA scan and bloodwork turned into an organ-by-organ risk score a doctor talks you through within 48 hours, and customers can’t pick and choose which parts to take.
🟢 Built by Shashank ND, Anshul Khandelwal and Arpit Garg | Since 2025
↓
There is something these five have in common. In every case the AI stops short of the final decision: a chemist still makes the molecule, a lawyer signs the contract, a developer ships the code, a recruiter places the candidate, a doctor reads the scan.
Every week we look past the AI headlines, to founders solving problems most of us never think about.
Know a founder solving a problem the rest of us have overlooked? Tell us, and we’ll put them on the radar.
💚 https://airadar.aiboomi.org
#AI #ProductNation
